Evolution of autoimmune hepatitis to primary sclerosing cholangitis: A sequential syndrome

Hepatology

Volumn 36, Issue 6, 2002, Pages 1393-1399

  Abdo, Ayman A ^a   Bain, Vincent G ^b   Kichian, Krikor ^b   Lee, Samuel S ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; LIVER ENZYME;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BILIARY TRACT DISEASE; CHOLESTASIS; CLINICAL ARTICLE; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE COURSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HAPLOTYPE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; SCLEROSING CHOLANGITIS; ULCERATIVE COLITIS;

EID: 0036895659     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.37200     Document Type: Article

References (24)

1. Gregorio GV, Portmann B, Karani J, Harrison P, Donaldson PT, Vergani D, Mieli-Vergani G. Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood: A 16-year prospective study. Hepatology 2001;33:544-553.
2. Koskinas J, Raptis I, Manika Z, Hadziyannis S. Overlapping syndrome of autoimmune hepatitis and primary sclerosing cholangitis associated with pyoderma gangrenosum and ulcerative colitis. Eur J Gastroenterol Hepatol 1999;11:1421-1424.
3. Gohlke F, Lohse AW, Dienes HP, Lohr H, Marker-Hermann E, Gerken G, Meyer zum Buschenfelde KH. Evidence of an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 1996;24:699-705.
4. McNair AN, Moloney M, Portmann BC, Williams R, McFarlane IG. Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases. Am J Gastroenterol 1998;93:777-784.
5. Luketic V, Gomez D, Sanyal A, Shiffman M. An atypical presentation for primary sclerosing cholangitis. Dig Dis Sci 1997;42:2009-2016.
6. Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis. Hepatology 1993;18:10-15.
7. Michieletti P, Wanless IR, Katz A, Scheuer PJ, Yeaman SJ, Bassendine MF, Heathcote J. Antimitochondrial antibody negative primary biliary cirrhosis: A distinct syndrome of autoimmune cholangitis. Gut 1994;35:260-265.
8. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31:929-938.
9. Roberts EA. Primary sclerosing cholangitis in children. J Gastroenterol Hepatol 1999;14:588-593.
10. Czaja AJ. Variant forms of autoimmune hepatitis. Curr Gastroenterol Rep 1999;1:63-70.
11. Chapman RWG, Arborgh BAM, Rhoes JM. Primary sclerosing cholangitis: A review of its clinical features, cholangiography, and hepatic histology. Gut 1980;21:870-877.
12. Zauli D, Schrumpf E, Crespi C. An autoantibody profile in primary sclerosing cholangitis. J Hepatol 1987;5:14-18.
13. Czaja AJ, Santrach PJ, Breanndan MS. Shared genetic risk factors in autoimmune liver disease. Dig Dis Sci 2001;46:140-147.
14. Chapman RWG. Role of immune factors in the pathogenesis of primary sclerosing cholangitis. Semin Liver Dis 1991;11:1-4.
15. Johnson PJ, McFarlane IG, Eddleston ALWF. The natural course and heterogeneity of autoimmune type chronic active hepatitis. Semin Liver Dis 1991;11:187-196.
16. Bodenheimer HC, LaRusso NA, Thayer WR. Elevated circulating immune complexes in primary sclerosing cholangitis. Hepatology 1983;3:150-154.
17. Whiteside TL, Lasky S, Si L, Van Thiel DH. Immunologic analyses of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis. Hepatology 1985;5:468-474.
18. Lindor KD, Wiesner RH, Katzmann JA. Lymphocyte subsets in primary sclerosing cholangitis. Dig Dis Sci 1987;32:720-725.
19. Boberg KM, Aadland E, Jahnsen J, Raknerud N, Stiris M, Bell H. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 1998;33:99-103.
20. Kaya M, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary sclerosing cholangitis: An evaluation of a modified scoring system. J Hepatol 2000;33:537-542.
21. van Buuren HR, van Hoogstraten HJE, Terkivatan T, Schalm SW, Vleggaar FP. High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis. J Hepatol 2000;33:543-548.
22. Czaja A, Carpenter H. Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology 2001;34:659-665.
23. Perdigoro R, Carpenter H, Czaja A. Frequency and significance of chronic ulcerative colitis in severe corticosreroid-treated autoimmune hepatitis. J Hepatol 1992;14:325-331.
24. Angulo P, Yaakov M-K, Lindor KD. Small-duct primary sclerosing cholangitis: A long-term follow-up study. Hepatology 2002;35:1494-1500.